Press Releases from DelveInsight (457 total)
Psoriasis Vulgaris Pipeline: 45+ Therapies in Development by Pharma Leaders Set …
The psoriasis vulgaris treatment landscape is witnessing robust advancement, spearheaded by biopharmaceutical innovators such as Xencor, Ono Pharmaceutical Co. Ltd, Boehringer Ingelheim, GC Cell Corporation,…
Short Bowel Syndrome Pipeline: 18+ Companies Driving Innovation in Rare Gastroin …
The treatment landscape for Short Bowel Syndrome (SBS) is witnessing meaningful progress, led by innovators like VectivBio, Zealand Pharma, 9 Meters Biopharma, Hanmi Pharmaceutical, Adocia,…
LEQVIO Sales Surge Globally, Driven by Rising Cardiovascular Risk Awareness and …
DelveInsight's "LEQVIO Market Size, Forecast, and Market Insight Report" delivers a comprehensive analysis of LEQVIO's commercial performance, competitive positioning, and future outlook across key global…
Necrotizing Enterocolitis Pipeline: Breakthrough Therapeutics Advancing in Neona …
Necrotizing Enterocolitis (NEC), a devastating gastrointestinal disease affecting neonates, especially preterm infants, has long lacked effective treatment beyond supportive care. However, innovative biotech companies such…
Steroid-Refractory Acute Graft-Versus-Host Disease Pipeline: Innovation Surge as …
Steroid-refractory acute graft-versus-host disease (SR-aGVHD) represents a severe and life-threatening complication of allogeneic stem cell transplantation, with limited treatment options and poor prognosis. Key companies,…
Polycythemia Vera Pipeline: 10+ Therapies in Development by Pharma Giants Poised …
The Polycythemia Vera (PV) treatment landscape is undergoing significant evolution, driven by leading biopharmaceutical companies such as Protagonist Therapeutics, Italfarmaco, Ionis Pharmaceuticals, and Perseus Proteomics.…
Cystitis Pipeline: 15+ Innovators Advancing Disease-Modifying and Symptomatic Th …
Cystitis, an inflammation of the bladder often caused by bacterial infection, has drawn significant attention from over 15 key companies, including Seikagaku Corporation, Lipella Pharmaceuticals,…
Chemotherapy-Induced Anemia Pipeline: 3+ Companies Advancing Novel Erythropoieti …
Chemotherapy-Induced Anemia (CIA) is a common and debilitating side effect of cancer treatment, significantly impacting patients' quality of life, fatigue levels, and treatment adherence. With…
Brain Hemorrhage Pipeline: 10+ Innovators Advancing Neuroprotective and Regenera …
Brain hemorrhage, a life-threatening condition characterized by bleeding within the brain tissue, has spurred the development of innovative treatments by more than 10 key pharmaceutical…
Candidiasis Pipeline: 15+ Key Innovators Advancing Therapeutic Solutions from Ci …
Candidiasis, a fungal infection caused by Candida species, is a growing concern in both immunocompromised and healthy populations. The candidiasis pipeline is being advanced by…
Cachexia Pipeline: 27+ Innovators Advancing Anti-Wasting and Metabolic Therapies …
Cachexia, a multifactorial syndrome marked by severe muscle wasting and weight loss, especially in cancer and chronic illnesses, has attracted growing R&D interest. Over 27…
Anthrax Pipeline: 10+ Companies Advancing Cutting-Edge Vaccines and Therapeutics …
The anthrax treatment market is evolving, with focused R&D efforts aimed at biodefense and preparedness for high-threat pathogens. Key players, including GC Pharma, Emergent BioSolutions,…
Angina (Angina Pectoris) Pipeline: 10+ Companies Transforming Chest Pain Managem …
The angina therapeutics pipeline is experiencing a renaissance, driven by pharmaceutical companies such as Abbott Laboratories, AstraZeneca, Bayer AG, and Bristol-Myers Squibb. With a focus…
Anaplastic Astrocytoma Pipeline: 15+ Biopharma Companies Advancing Targeted Ther …
The anaplastic astrocytoma treatment pipeline is gaining momentum with the introduction of precision therapies, immunotherapies, and novel alkylating agents. Companies like Orbus Therapeutics, Cothera Bioscience,…
Actinic Keratosis Pipeline: 10+ Key Players Driving Innovation in Non-Invasive D …
The actinic keratosis (AK) treatment landscape is expanding rapidly, driven by key players such as Biofrontera, Almirall, and Leo Pharma. The current pipeline includes next-generation…
Acinetobacter Infections Pipeline: 7+ Biopharma Players Combatting Antimicrobial …
Acinetobacter infections, especially those caused by Acinetobacter baumannii, remain a critical concern due to rising antimicrobial resistance. Leading biotech firms, such as Omnix Medical, Roche,…
Gaucher's Disease Type III Pipeline: 7+ Developers Advancing Targeted CNS Therap …
Gaucher's Disease Type III, the chronic neuronopathic form, is gaining targeted attention from over 7 companies, including Sanofi Genzyme, CANbridge Pharmaceuticals, AVROBIO, and Orphazyme. The…
Sandhoff Disease Pipeline: 5+ Biotech Firms Driving Rare Disease Innovation Thro …
Sandhoff Disease, a rare and fatal lysosomal storage disorder, is seeing progress through the efforts of over 5 companies, including IntraBio, Sanofi, Polaryx Therapeutics, and…
Lewy Body Disease Pipeline: 10+ Innovators Advancing Disease-Modifying and Sympt …
Lewy Body Disease (LBD), including dementia with Lewy bodies and Parkinson's disease dementia, is a complex neurodegenerative condition attracting the attention of over 10 key…
Klebsiella Infections Pipeline: 7+ Companies Targeting Multi-Drug Resistance wit …
With rising concerns over antibiotic-resistant Klebsiella strains, more than 7 companies are actively developing cutting-edge therapies, including Nosopharm, Debiopharm, and Locus Biosciences. The Klebsiella infections…
Norovirus Infection Pipeline: 8+ Leading Companies Advancing Breakthrough Vaccin …
The Norovirus infection pipeline is gaining momentum with 8+ pharmaceutical companies pursuing innovative solutions, including Prosit Sole Biotechnology, HilleVax, iosBio, and OstriGen. These players are…
The Global DNA Sequencing Market is Projected to Grow at a CAGR of ~18.02% by 20 …
The DNA sequencing market is experiencing robust growth fueled by several critical factors, including the rising incidence of genetic disorders and cancer, increasing applications of…
The Global Biopsy Devices Market Poised for Unstoppable Growth by 2032, Driven b …
The biopsy devices market is experiencing significant growth, fueled by key factors such as the increasing incidence of cancer and other chronic diseases, advancements in…
IgA Nephropathy Market Set for Exceptional Growth by 2034 - DelveInsight | Key P …
IgA Nephropathy, a leading cause of kidney disease worldwide, continues to challenge both patients and healthcare systems with its complex progression and limited treatment options.…
Pulmonary Arterial Hypertension Market Set for Remarkable Growth by 2034 - Delve …
Pulmonary Arterial Hypertension (PAH) is a progressive and life-threatening condition characterized by high blood pressure in the arteries of the lungs, leading to heart failure…
ENTYVIO Sales Surge Globally, Driven by Growing IBD Prevalence and Physician Dem …
DelveInsight's "ENTYVIO Market Size, Forecast, and Market Insight Report" offers in-depth analysis of ENTYVIO sales, positioning, and market outlook across major geographies. Developed by Takeda…
Advanced Gastric Carcinoma Pipeline: 50+ Visionary Companies Pioneering the Next …
The advanced gastric carcinoma market is experiencing a wave of groundbreaking innovations, driven by pioneering companies such as GeneQuantum Healthcare (Suzhou), Janssen Pharmaceutical K.K., Shanghai…
Retinitis Pigmentosa Market Poised for Transformative Expansion by 2034 - DelveI …
Retinitis Pigmentosa, a group of inherited retinal disorders, continues to impose a significant burden on patients and healthcare systems worldwide. Driven by an increasing prevalence…
PD-1 and PD-L1 Inhibitors Competitive Landscape: 180+ Trailblazing Companies Red …
The PD-1 and PD-L1 inhibitors pipeline is on fire, with industry giants like Celgene, MedImmune, and Hangzhou Sumgen Biotech leading the charge. These game-changing immunotherapies…
Vestibular Schwannoma Pipeline: 10+ Pioneering Companies Revolutionizing Innovat …
The vestibular schwannoma treatment landscape is on the brink of a revolution, powered by disruptive therapies from pioneering companies like NeuroPharm and OrthoMed. With a…
Immunologic Deficiency Syndrome Pipeline: 40+ Visionary Companies Pioneering the …
The immunologic deficiency syndrome market is witnessing a surge in breakthrough innovations, spearheaded by trailblazers like Mustang Bio, Bellicum Pharmaceuticals, Lactiga, and GC Pharma. Cutting-edge…
Hepatitis C Virus Infection Pipeline: 20+ Leading Companies Shaping the Future o …
The Hepatitis C Virus (HCV) infection market is experiencing robust pipeline advancements, led by companies such as Genecure Biotechnologies Preclinical, iQur, and Atea Pharmaceutical. With…
Inflammatory Bowel Disease Market Set to Undergo Transformative Growth by 2034 - …
Inflammatory Bowel Disease, encompassing ulcerative colitis and Crohn's disease, continues to impose a significant burden on patients and healthcare systems worldwide. Driven by an increasing…
Homozygous Familial Hypercholesterolemia Market Poised for Transformative Growth …
Homozygous Familial Hypercholesterolemia (HoFH), a severe and ultra-rare genetic disorder, has long posed therapeutic challenges due to its aggressive cardiovascular complications and limited treatment options.…
Pyoderma Gangrenosum Market Set to Undergo Transformative Growth by 2032 - Delve …
Pyoderma gangrenosum, rare and painful neutrophilic dermatoses, is garnering growing clinical and research attention due to its complex pathogenesis and unmet therapeutic needs. With advancements…
Human Papillomavirus Market Set for Breakthrough Expansion by 2034, Driven by In …
Curious about the rapid evolution of the human papillomavirus market? DelveInsight's latest 7MM report uncovers crucial epidemiological patterns, transformative market trends, and highlights leading innovators…
Global Aesthetic Implants Market Set to Grow at a CAGR of 7.82% by 2032, Driven …
The aesthetic implants market is experiencing positive growth due to factors such as the increasing demand for cosmetic enhancement procedures, a growing aging population seeking…
Heart Failure Pipeline: 70+ Pioneering Companies Advancing the Next Wave of Inno …
The heart failure therapeutics and device market is experiencing a significant transformation, driven by key innovators such as Moderna Therapeutics, Cytokinetics, Applied Therapeutics, Help Therapeutics,…
Chronic Pulmonary Infections Pipeline: 10+ Leading Companies Driving the Next Wa …
The chronic pulmonary infections market is undergoing a significant transformation, driven by pioneering companies such as Chiesi Farmaceutici, Armata Pharmaceuticals, Genentech, Altesa Biosciences, and Kinaset…
ATTR Amyloidosis Pipeline: 10+ Leading Companies Shaping the Future of Groundbre …
The ATTR amyloidosis therapeutics market is witnessing a significant evolution, driven by trailblazing companies such as Novo Nordisk, Sirnaomics, and Arbor Bio. With the advent…
Alcohol Use Disorder Pipeline: 30+ Leading Companies Driving the Next Generation …
The Alcohol Use Disorder treatment market is undergoing a significant transformation, driven by trailblazers like Cybin, Indivio, BioXcel Therapeutics, BiocorRx Pharmaceuticals, Beckley Psytech, and MediciNova.…
Relapsing-Remitting Multiple Sclerosis Pipeline: 25+ Leading Innovators Paving t …
The relapsing-remitting multiple sclerosis (RRMS) therapeutics market is experiencing a significant transformation, driven by key innovators like Immunic AG, Sanofi, Anokion, RemeGen, HuniLife Biotechnology, Biogen,…
Atherosclerosis Pipeline: 15+ Trailblazing Companies Driving the Future of Innov …
The atherosclerosis market is experiencing a wave of therapeutic innovation, driven by key players such as Novo Nordisk, Amgen, Merck Sharp & Dohme, Afimmune, Silence…
Malaria Pipeline: 15+ Pioneering Companies Advancing the Next Wave of Innovative …
The malaria therapeutics and vaccine market is undergoing a critical transformation, led by innovators such as Sanaria, GlaxoSmithKline, Novartis, Bharat Biotech, and GeoVax. With the…
Hypercholesterolemia Pipeline: 25+ Leading Innovators Driving the Future of Chol …
The hypercholesterolemia market is being reshaped by biologics, RNA-based therapies, and gene-editing tools developed by industry leaders such as Amgen, Novartis, Verve Therapeutics, Arrowhead Pharmaceuticals,…
T-Cell Lymphoma Pipeline: 90+ Leading Companies Transforming the Landscape of Ta …
The T-cell lymphoma market is rapidly evolving with targeted therapies and immuno-oncology agents spearheaded by companies like Astex Pharmaceuticals, Corvus Pharmaceuticals, ViGenCell Inc., Affimed GmbH,…
Tuberculosis Pipeline: 30+ Innovators Paving the Way for Breakthrough Therapies …
The tuberculosis market is gaining renewed momentum with the development of advanced vaccines and novel drug regimens by key players such as Biofabri, Serum Institute…
Staphylococcal Infections Pipeline: 22+ Innovators Shaping the Future of Antibac …
Staphylococcal infections, caused by Staphylococcus bacteria, range from minor skin issues to severe conditions like pneumonia and sepsis. The rise of antibiotic-resistant strains, such as…
Sensorineural Hearing Loss Pipeline: 20+ Innovators Shaping the Future of Hearin …
The sensorineural hearing loss space is entering a transformative phase with groundbreaking innovations in gene therapy and regenerative medicine. Pioneering companies such as Sensorion, AudioCure…
Urticaria Pipeline: 20+ Innovators Driving the Next Wave of Advanced Treatment O …
The urticaria space is entering an exciting era of innovative treatment development, with leading companies such as Regeneron Pharmaceuticals, Taiho Pharmaceutical Co., Ltd, Allakos Inc,…
